HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 182 filers reported holding HERON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,053,283 | -0.1% | 1,022,605 | +12.6% | 0.00% | – |
| Q2 2023 | $1,053,945 | -29.1% | 908,573 | -7.6% | 0.00% | – |
| Q1 2023 | $1,485,481 | -38.2% | 983,762 | +2.3% | 0.00% | -100.0% |
| Q4 2022 | $2,403,225 | -41.9% | 961,290 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $4,134,000 | +55.1% | 979,570 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $2,666,000 | -49.1% | 955,461 | +4.4% | 0.00% | 0.0% |
| Q1 2022 | $5,237,000 | -40.4% | 915,569 | -4.8% | 0.00% | 0.0% |
| Q4 2021 | $8,780,000 | -15.0% | 961,690 | -0.5% | 0.00% | -50.0% |
| Q3 2021 | $10,335,000 | -30.8% | 966,657 | +0.5% | 0.00% | -33.3% |
| Q2 2021 | $14,930,000 | -3.8% | 961,953 | +0.5% | 0.00% | 0.0% |
| Q1 2021 | $15,513,000 | -26.7% | 957,017 | -4.2% | 0.00% | -25.0% |
| Q4 2020 | $21,151,000 | +39.6% | 999,360 | -2.2% | 0.00% | +33.3% |
| Q3 2020 | $15,150,000 | -4.7% | 1,022,275 | -5.4% | 0.00% | -25.0% |
| Q2 2020 | $15,894,000 | +34.5% | 1,080,537 | +7.3% | 0.00% | +33.3% |
| Q1 2020 | $11,819,000 | -49.4% | 1,006,642 | +1.3% | 0.00% | -40.0% |
| Q4 2019 | $23,343,000 | +38.1% | 993,352 | +8.7% | 0.01% | +25.0% |
| Q3 2019 | $16,902,000 | +6.8% | 913,621 | +7.4% | 0.00% | 0.0% |
| Q2 2019 | $15,820,000 | -23.0% | 851,035 | +1.2% | 0.00% | -20.0% |
| Q1 2019 | $20,556,000 | -5.3% | 841,072 | +0.5% | 0.01% | -16.7% |
| Q4 2018 | $21,701,000 | -18.6% | 836,535 | -0.8% | 0.01% | -14.3% |
| Q3 2018 | $26,676,000 | -9.9% | 842,900 | +10.6% | 0.01% | -12.5% |
| Q2 2018 | $29,616,000 | +70.8% | 762,315 | +21.4% | 0.01% | +60.0% |
| Q1 2018 | $17,335,000 | +76.4% | 628,068 | +15.7% | 0.01% | +150.0% |
| Q4 2017 | $9,827,000 | +14.1% | 542,959 | +1.8% | 0.00% | 0.0% |
| Q3 2017 | $8,614,000 | +11.8% | 533,464 | -4.1% | 0.00% | 0.0% |
| Q2 2017 | $7,706,000 | +1.5% | 556,407 | +10.0% | 0.00% | 0.0% |
| Q1 2017 | $7,591,000 | +58.0% | 506,053 | +38.0% | 0.00% | +100.0% |
| Q4 2016 | $4,803,000 | -22.2% | 366,685 | +2.4% | 0.00% | -50.0% |
| Q3 2016 | $6,173,000 | -4.2% | 358,265 | +0.4% | 0.00% | 0.0% |
| Q2 2016 | $6,443,000 | -0.7% | 356,979 | +4.5% | 0.00% | 0.0% |
| Q1 2016 | $6,487,000 | -29.0% | 341,584 | -0.2% | 0.00% | -33.3% |
| Q4 2015 | $9,143,000 | +14.6% | 342,416 | +4.7% | 0.00% | 0.0% |
| Q3 2015 | $7,979,000 | -5.9% | 327,008 | +20.1% | 0.00% | 0.0% |
| Q2 2015 | $8,481,000 | +122.6% | 272,178 | +4.0% | 0.00% | +200.0% |
| Q1 2015 | $3,810,000 | +46.4% | 261,833 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $2,602,000 | +33.4% | 258,683 | +10.5% | 0.00% | 0.0% |
| Q3 2014 | $1,950,000 | +235.6% | 234,079 | +396.9% | 0.00% | – |
| Q2 2014 | $581,000 | +95.0% | 47,107 | +119.6% | 0.00% | – |
| Q1 2014 | $298,000 | – | 21,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |